TY - JOUR
KW - gout
KW - crystal arthritis
KW - hospitalisations
KW - treat-to-target
KW - urate-lowering therapy
AU - M. Russell
AU - E. Roddy
AU - A. Rutherford
AU - B. Ellis
AU - S. Norton
AU - A. Douiri
AU - M. Gulliford
AU - A. Cope
AU - J. Galloway
AD - Centre for Rheumatic Diseases, King's College London, UK.
School of Medicine, Keele University, UK, Keele.
Department of Rheumatology, King's College Hospital NHS Foundation Trust, London, UK.
Department of Rheumatology, Imperial College Healthcare NHS Foundation Trust, London, UK.
School of Population Health and Environmental Sciences, King's College London, London, UK.
AN - 36355461
BT - Rheumatology (Oxford)
DO - 10.1093/rheumatology/keac638
DP - NLM
ET - 2022/11/11
LA - eng
N1 - 1462-0332
Russell, Mark D
Orcid: 0000-0001-8171-7772
Roddy, Edward
Rutherford, Andrew I
Ellis, Benjamin
Norton, Sam
Douiri, Abdel
Gulliford, Martin C
Cope, Andrew P
Galloway, James B
Journal Article
England
Rheumatology (Oxford). 2022 Nov 10:keac638. doi: 10.1093/rheumatology/keac638.
PY - 2022
SN - 1462-0324
T2 - Rheumatology (Oxford)
TI - Treat-to-target urate-lowering therapy and hospitalisations for gout: results from a nationwide cohort study in England
ER -